KASSANDRA JOHNS: Open Payments
NPI 1649037409 · OVERLAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$991 in 55 payments from 24 companies in 2025. Trend: 2023 $0 · 2024 $519 · 2025 $991
Food & beverage: $991
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $148 |
| AstraZeneca Pharmaceuticals LP | 6 | $104 |
| Lilly USA, LLC | 4 | $89 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $77 |
| Axsome Therapeutics, Inc. | 4 | $68 |
| ABBVIE INC. | 3 | $48 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $44 |
| GlaxoSmithKline, LLC. | 2 | $41 |
| Otsuka America Pharmaceutical, Inc. | 2 | $32 |
| Viatris Specialty LLC | 2 | $30 |
Products named: JARDIANCE, Ozempic, Wegovy, MOUNJARO, Auvelity, CAPLYTA, TRELEGY ELLIPTA, AIRSUPRA.
Industry payments across KS — which companies pay providers there.
